Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Q2 2022 Earnings Conference Call August 3, 2022 4:30 PM ET
Company Participants
Susan Morrison - Executive VP & Chief Administrative Officer
John Sheridan - President, CEO & Director
Brian Hansen - EVP & Chief Commercial Officer
Leigh Vosseller - EVP, CFO & Treasurer
Conference Call Participants
Steven Lichtman - Oppenheimer
Brooks O'Neil - Lake Street Capital Markets
Travis Steed - Bank of America Merrill Lynch
Jayson Bedford - Raymond James & Associates
Matthew O'Brien - Piper Sandler & Co.
Christopher Pasquale - Nephron Research
Dane Reinhardt - Robert W. Baird & Co.
Operator
Thank you for standing by, and welcome to Tandem's Second Quarter 2022 Earnings Conference Call. [Operator Instructions]. As a reminder, today's program is being recorded. And now I'd like to introduce your host for today's program, Susan Morrison, Executive Vice President and Chief Administrative Officer. Please go ahead.
Susan Morrison
Good afternoon, and welcome to Tandem's Second Quarter Earnings Call. Today's discussion will include forward-looking statements. These statements reflect management's expectations about future events, product development time lines and financial performance and operating plans and speak only as of today's date. There are risks and uncertainties that could cause actual results to differ materially from those anticipated or projected in our forward-looking statements.
A list of factors that could cause actual results to be materially different from those expressed or implied by any of these forward-looking statements is highlighted in our press release issued earlier today and under the Risk Factors portion and elsewhere in our most recent annual report on Form 10-K, quarterly report on Form 10-Q and in our other SEC filings. We assume no obligation to publicly update any forward-looking statements whether as a result of new information, future events or other factors.
In addition, today's discussion will include references to adjusted EBITDA, which is a non-GAAP financial measure. Adjusted EBITDA is a key measure used by us to evaluate operating performance, generate future operating plans and make strategic decisions for the allocation of capital. Please refer to our press release issued earlier today for further information.
Our call today will be led by John Sheridan, our President and CEO, and he'll be joined by Brian Hansen, our EVP and Chief Commercial Officer, and Leigh Vosseller, our EVP and Chief Financial Officer. Following their prepared remarks, we'll open up the call for questions. Thank you in advance for limiting yourself to 1 question and 1 follow-up before getting back into the queue. I'll now turn the call over to John.